MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-TN-08-0032569
Sendan Pharmaceuticals Private Limited
Sendan Pharmaceuticals Private Limited - chemicals in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.94 Cr
▲ 30% YoY
Net profit · FY 2025
₹8.12 Lakh
Net margin 4.2%
EBITDA · FY 2025
₹14.66 Lakh
EBITDA margin 7.6%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹45 Lakh
Secured borrowings
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
About Sendan Pharmaceuticals Private Limited
Data last updated:
Sendan Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 12 November 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24239TN2021PTC147847. Its GSTIN is 37ABHCS2803A1ZR (Andhra Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nidubrolu Lakshmi Kumari and Maddiguntla Neelima.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Villa No Iiic Jones Cassia Ottiyambakkam, Chennai, Tamil Nadu, India – 600130.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.94 Cr, a growth of 30% compared to the previous year. For the same year it recorded a net profit of ₹8.12 Lakh (net margin 4.2%) and EBITDA of ₹14.66 Lakh (EBITDA margin 7.6%).
As per MCA filings, the company has open charges of ₹45 Lakh on record.
Sendan Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-08-0032569).
Company details
CIN U24239TN2021PTC147847
Registration Number 147847
Incorporation Date 12 November 2021
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-TN-08-0032569
Recognitions & Rankings of Sendan Pharmaceuticals
Contact details
Sendan Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address is in the company report.
- Email
- Registered AddressVilla No Iiic Jones Cassia Ottiyambakkam, Chennai, Tamil Nadu, India – 600130
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Sendan Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Sendan Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Sendan Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Sendan Pharmaceuticals Private Limited, buy the company report.
Financials of Sendan Pharmaceuticals Private Limited
FY 2025 filings availableSendan Pharmaceuticals Private Limited reported revenue of ₹1.94 Cr (up 30% YoY) for FY 2025.
Revenue · FY 2025
₹1.94 Cr ▲ 30%
Net profit · FY 2025
₹8.12 Lakh margin 4.2%
EBITDA · FY 2025
₹14.66 Lakh margin 7.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 30%
EBITDA CAGR growth
1 year
▲ 32%
3 years · compounded
▲ 96%
Revenue rose 30% in the latest year. EBITDA rose 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹14.66 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹8.12 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 7.6% | |||
| Net Profit Margin | 4.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Sendan Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sendan Pharmaceuticals Private Limited
Sendan Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nidubrolu Lakshmi Kumari | Director | 12 Nov 2021 | 4 Years 11 Months | Current |
| Maddiguntla Neelima | Director | 12 Nov 2021 | 4 Years 11 Months | Current |
Charges & borrowings
Open charges
₹45 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Dec 2025 | 101209200 | State Bank of India | ₹45 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Sendan Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sendan Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Sendan Pharmaceuticals Private Limited has 1 active EPFO establishment as of Mar 30, 2024.
Active EPFO establishments
1
GST
Sendan Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37ABHCS2803A1ZR | Andhra Pradesh | Active | 06 Jan 2022 |
To see the full GST registrations and return filing status of Sendan Pharmaceuticals Private Limited, buy the company report.
Recent activity
Sendan Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Maddiguntla Neelima was appointed as Director on 12 Nov 2021.
Charges
A charge with State Bank Of India amounted to Rs. 45.00 Lakh with Charge ID 101209200 was registered on 30 Dec 2025.
AGM
Sendan Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Sendan Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Appointed
Maddiguntla Neelima was appointed as Director.
Appointed
Nidubrolu Lakshmi Kumari was appointed as Director.
Incorporation
12 Nov 2021
Sendan Pharmaceuticals Private Limited was registered on 12 Nov 2021 with Roc Chennai & aged 4 years 11 months as per MCA records.
Frequently asked questions
Sendan Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 12 November 2021 (5+ years old) and is registered under CIN U24239TN2021PTC147847.
Sendan Pharmaceuticals has 2 current directors:
- Nidubrolu Lakshmi Kumari - Director
- Maddiguntla Neelima - Director
The latest financial statements of Sendan Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Sendan Pharmaceuticals is 37ABHCS2803A1ZR, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Sendan Pharmaceuticals is U24239TN2021PTC147847. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sendan Pharmaceuticals was incorporated on 12 November 2021, making it 5+ years old. It is registered with the Registrar of Companies, Chennai.
Maddiguntla Neelima was appointed as Director on 12 Nov 2021. Nidubrolu Lakshmi Kumari was appointed as Director on 12 Nov 2021.
Yes, Sendan Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-08-0032569).
The registered office of Sendan Pharmaceuticals is at Villa No Iiic Jones Cassia Ottiyambakkam, Chennai, Tamil Nadu, India – 600130.
Sendan Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages